initi buy pt ampl room grow
nich prepaid card issuer payment processor
initi coverag tpnl buy
recommend price target base compani
ebitda tpnl vertic integr prepaid debit
card payment provid plasma donat industri
featur high revenu growth rate busi recession-resist
well strong increment margin believ compani well
posit increas market share plasma donat space
take advantag non-plasma growth opportun
pharmaceut co-pay gener purpos reload gpr prepaid debit
attract small-cap compani pois sustain high revenu
growth rate compound-annual-growth-rate sinc healthi adjust ebitda
margin ttm driven part plasma donat
center open market share gain believ tpnl
larg overlook undercov benefit custom
oper plasma donat center open new locat take
market share lead competitor wirecard
wdi gr rate aid superior level servic nearli
increment growth opportun includ expans
pharmaceut program incent rebat program
gpr card marketplac tpnl leverag proprietari
pre-paid technolog platform expand pharma co-pay
pre-paid debit card busi launch gpr card cross-sel
holder plasma donat card therebi gain access
support stock multipl tpnl sign five-year contract
plasma donat center three-year renew
retent rate five year run
valuat price target tpnl base
compani ebitda
btig estim compani document million except per share amount
pleas read import disclosur analyst certif appear appendix
invest thesi analysi
attract small-cap compani pois sustain high revenu growth rate
compound-annual-growth-rate sinc healthi adjust ebitda margin
ttm driven part plasma donat center open market share
believ tpnl well posit sustain high rate revenu growth
strong adjust ebitda margin thank larg part strong servic
offer particularli rel wirecard wdi gr rate
continu command largest market share industri
believ tpnl abl win vast major contract
approxim new plasma donat center expect open
year next sever year combin signific number
conquest competitor expir contract abl
boost market share meaning
btig estim compani report
 plasma donat center industri domin four
octapharma privat shire bought last year takeda tak
rate japanes pharmaceut compani tpnl strong
relationship largest fastest-grow plasma firm
industri grant compani clear major
contract open new center state intend open
center per year next sever year
meanwhil tpnl abl convert larg number center
grifol second-largest player plasma industri
tpnl gener revenu growth plasma donat busi open
new center market grow mid- high-singl digit
increas number donat per center inflat donor
compens competit donor result increas
compens per year
believ tpnl success build market share sinc
enter pharma donat industri due larg part superior
level servic versu peer howev also think competit
advantag prepaid debit card program manag
payment processor contrast end-to-end capabl tpnl
competitor either program manag processor
increment growth opportun includ expans pharmaceut
program incent rebat program gener purpos
addit tpnl plasma donat card busi compani
leverag proprietari pre-paid technolog platform expand
pharma co-pay pre-paid debit card busi also use platform
launch gpr card cross-sel holder plasma donat card
therebi gain access sticki direct deposit employ govern
platform built cross-platform architectur provid
tpnl flexibl scalabl eas custom expand
oper pharmaceut co-pay gpr card initi
platform oper uptim significantli reduc
tpnl time cost card program develop importantli enabl
compani custom card program meet uniqu requir
custom capabl competitor lack cost-prohibit
tpnl also seek grow pharma co-pay pre-paid debit card busi
partner larg pharmaceut compani creat loyalti
program incent program user drug reduc out-
of-pocket payment pharma compani program receiv
valuabl custom data influenc purchas decis
tpnl pharma co-pay pre-paid card debit card busi prior
enter plasma donat space gener revenu
compani shift focu plasma donat busi
disput partner pskw payment compani outsourc
portion card busi tpnl exchang portion revenu
pskw believ money remain expir card belong
tpnl saw thing differ parti went court tpnl
chang direct busi strategi settl suit
tpnl pursu revenu opportun within pharma
co-pay card space believ compani could gener revenu
busi
tpnl also intend leverag technolog capabl expand
incent rebat program industri vertic
tpnl plan launch new premier gpr card end
compani intend cross-sel gpr card
holder plasma donat card success tpnl gain access
sticki direct deposit employ govern assist program
new sourc recur revenu believ program
well posit succeed inasmuch plasma donor demograph
group tend unbank underbank therefor repres good
target audienc store valu card premier gpr card
also offer bill pay money transfer remot deposit captur opt-in
btig estim compani report
assum tpnl abl convert plasma
donat cardhold premier card believ
averag spend custom could increas sinc user
gpr typic load fund moreov manag believ
custom acquisit cost gpr card first quarter
launch zero sinc target exist plasma donat
note former netspend ceo henri join tpnl may
chairman board director believ bode well
likelihood success compani non-plasma effort henri ceo
netspend guid compani growth ebitda
sold total system servic tss rate
cash prior join netspend henri co-found
presid euronet rate
sticki custom predict revenu stream support stock multipl
tpnl sign five-year contract plasma donat center
three-year renew retent rate five year run
compani superior servic attribut superior level servic
featur in-hous bilingu custom care note servic
rather price primari order winner among plasma donor center
prepaid debit card fee paid donor plasma compani
result tpnl outstand retent rate revenu stream
predict believ predict one sever factor includ
revenu growth greater gross margin greater
ebitda margin greater compani stock merit
countercycl busi suppli plasma donor increas
plasma donat increas recess peopl seek addit
fund replac lost reduc wage plasma donat increas
significantli onset great recess jump
high roe strong free cash flow debt posit option rise
tpnl ttm roe figur facilit compani
receipt everi plasma donat center servic low
compani gener strong free cash flow thank part low capit
intens septemb cash debt
tpnl earn interest float prepaid debit card issu
collect cash plasma center front donor spend
balanc time result tpnl posit earn interest
incom rate rise compani float
manag well align sharehold ownership
tpnl led highli experienc manag team strong record
valu creation own compani stock well
align sharehold co-found ceo presid mark newcom
own tpnl share fellow co-found chief
technolog offic daniel spenc own share
price target tpnl base compani
ev/ebitda valuat base compar compani
believ tpnl merit multipl use given organ revenu growth
rate context gross margin adjust ebitda margin greater
respect believ multipl support
predict compani recur revenu
risk valuat price
custom concentr tpnl deriv signific amount revenu
small number plasma donat center oper loss
one custom would significantli impact compani oper result
competit tpnl compet wirecard wdi gr rate servic
plasma donat center compani gain
market share need compet effect wdi sustain
regul plasma industri impact donor compens
 one countri world compens plasma
donor legal regul chang plasma donor
compens would signific advers impact
technolog risk tpnl technolog platform close
uptim mishap technolog could damag compani
reput therebi imped growth
rel small capit limit trade volum tpnl small
cap stock rel light trade volum liquid name
btig estim factset data compani document ebitda ev/ebitdacompani nametickerlast revenu revenu ebitda growth
compani industri overview
tpnl vertic integr prepaid debit card
payment solut provid payment processor plasma donat
industri compani design develop payment solut prepaid card
program custom payment servic brand
tpnl found septemb card
program cardhold compani gener revenu
collect variou fee associ prepaid debit card
issu client set-up implement fee program manag fee
consult servic fee custom mainten administr
 plasma donat industri histor use cash pay donor
typic paid theft account challeng fact
mani donor lack check account gave rise prepaid debit card
use almost donor payment tpnl one two primari
compani compet market prepaid debit card plasma
donat wirecard wdi gr rate enter
space acquir citi prepaid servic america
rate also minor presenc market tpnl
enter plasma donat card industri market share
center
tpnl offer visa-brand rate card oper kiosk
plasma donat center offer custom support includ
abil check card balanc fee charg compani
typic valu store card revenu
donat payment load card tpnl also gener
revenu interchang fee paid card network time card
use donor
 plasma donat center industri domin four
compani au rate grifol grf sm rate shire
bought last year takeda tak rate japanes
gr rate kendrion kendr na rate interst privat
plasma straw-color part blood repres blood volum
compris water protein plasma firm extract
protein donat plasma research use develop prescript
drug chronic genet ill immun defici physician also
use plasma treat shock trauma burn victim given restrict
payment plasma donor countri fda requir
plasma donat use therapi
world plasma suppli deriv
plasma industri donat grew accord
plasma protein therapeut associ plasma donat
center center averag donat per year base
typic fee typic donat payment one produc
per year
mark newcom co-found vice chairman presid chief
execut offic newcom serv tpnl presid chief
execut offic sinc march time also serv
director newcom also serv compani chairman march
may point elect vice chairman co-found
inc daniel spenc
serv tpnl chief technolog offic serv director sinc
march respons design architectur paysign
payment platform prior found inc co-found
newcom spenc director technolog plan associ
press world largest news gather organ
employe countri employ senior role
year decad payment process
mark atting chief financi offic atting serv tpnl chief
financi offic appoint decemb atting began
career spent year variou posit
financ perform qualiti manag oper
subsequ held posit vice presid oper nextcard
chief oper offic prudenti chief execut offic affina
led compani manag buy-out success
sale foreign conglomer recent atting serv chief
execut offic chief offic start-up zxerex
joan herman chief oper offic herman serv tpnl chief
oper offic sinc octob previous serv senior vice
presid payment divis sunris bank led compani
posit oper product develop sale market umb
heartland boatmen
al negron senior vice presid busi develop negron
join tpnl decemb charg pharma co-pay off-set
reimburs product busi veteran
bio/pharmaceut servic industri consult brand launch
team product manufactur alcon allergan novarti
robert strobo gener counsel chief legal offic secretari strobo
serv tpnl gener counsel chief legal offic secretari sinc
octob prior join compani serv deputi gener
counsel vice presid republ bank trust compani
special prepaid card issuanc non-tradit bank
includ small-dollar consum lend commerci lend payment
tax-rel financi product
btig cover compani mention report
appendix analyst certif import disclosur
